Copharos Report issue

For profit Phase 1
Founded: Ponte Vedra Beach FL United States (2000)
Status: Defunct (2002)

Organization Overview

First Clinical Trial
2002
NCT00040430
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2002

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

111in-daclizumab (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Neoplasms (Phase 1)

Breast Neoplasms (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 1)

Lung Neoplasms (Phase 1)

Neoplasm Metastasis (Phase 1)

Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 1